Exact Mass: 502.0991

Exact Mass Matches: 502.0991

Found 12 metabolites which its exact mass value is equals to given mass value 502.0991, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Garciduol B

2-[2,4-dihydroxy-3-(3-hydroxybenzoyl)-6-methoxyphenyl]-1,4,5-trihydroxy-9H-xanthen-9-one

C27H18O10 (502.09)


Garciduol B is found in fruits. Garciduol B is a constituent of Garcinia dulcis (mundu). Constituent of Garcinia dulcis (mundu). Garciduol B is found in fruits.

   

SCHEMBL13922309

SCHEMBL13922309

C31H18O7 (502.1052)


   

Garciduol B

2-{2,4-dihydroxy-3-[(3-hydroxyphenyl)carbonyl]-6-methoxyphenyl}-1,4,5-trihydroxy-9H-xanthen-9-one

C27H18O10 (502.09)


   

3,5-Bis(3,5-dimethoxybenzyloxy)benzyl Bromide

3,5-Bis(3,5-dimethoxybenzyloxy)benzyl Bromide

C25H27BrO6 (502.0991)


   

Tafamidis meglumine

Tafamidis meglumine

C21H24Cl2N2O8 (502.091)


C87006 - Pharmacological Chaperone

   

Capmatinib Hydrochloride

Capmatinib Hydrochloride

C23H21Cl2FN6O2 (502.1087)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   

N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C21H24F2N2O6S2 (502.1044)


   

6-[(3-Carboxy-3-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propanoyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[(3-Carboxy-3-hydroxy-2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}propanoyl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C20H22O15 (502.0959)


   

1-[1-(2-chlorophenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-[1,3]thiazolo[4,5-g]indazol-7-yl]-3-(1H-imidazol-2-ylmethyl)urea

1-[1-(2-chlorophenyl)-3-(pyridin-3-yl)-4,5-dihydro-1H-[1,3]thiazolo[4,5-g]indazol-7-yl]-3-(1H-imidazol-2-ylmethyl)urea

C24H19ClN8OS (502.1091)


   

2-[(3-{4-[(6-Carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-3-methoxyphenyl}prop-2-enoyl)oxy]-3-hydroxybutanedioic acid

2-[(3-{4-[(6-Carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-3-methoxyphenyl}prop-2-enoyl)oxy]-3-hydroxybutanedioic acid

C20H22O15 (502.0959)


   

LPI 8:3;O3

LPI 8:3;O3

C17H27O15P (502.1088)


   

GSK2647544

GSK2647544

C24H18ClF3N4O3 (502.1019)


GSK2647544 is an orally available, selective inhibitor of Lp-PLA2. Lipoprotein-associated phospholipase (Lp-PLA2) is a calcium-independent phospholipase A2 with proinflammatory activities that is primarily secreted by monocyte-derived macrophages[1].